loading page

ECONOMIC COSTS OF HOSPITALIZATION AND LENGTH OF STAY IN DIABETES WITH CO-EXISTING HYPERTENSION WITH CORRELATION TO LABORATORY INVESTIGATIONS: WHERE DOES INDIA STAND? A FIVE YEARS GROUND REPORT
  • Amit Sharma,
  • Ashish Baldi,
  • Dinesh Kumar Sharma
Amit Sharma
Research Scholar, Uttarakhand Technical University, Dehradun, ISF College of Pharmacy
Author Profile
Ashish Baldi
Maharaja Ranjit Singh Punjab Technical University
Author Profile
Dinesh Kumar Sharma
Roorkee College of Pharmacy
Author Profile

Abstract

Introduction: The coexistence of diabetes mellitus (DM) and hypertension (HTN) worsen clinical outcomes and contribute to increased morbidity and mortality. Objective: This study aims to analyze the length of stay and healthcare costs by calculating the direct and indirect costs of diabetes with co-existing hypertension in North India. Methods: A prospective observational study was conducted at the medicine department of the three different hospitals. Results: The patients’ mean age was found to be (M=53.8, SD=11.5) years. Out of 1914 patients, 53.65% were found female. Our study revealed that the median cost of medical supplies and equipment was found to be 21.2 $. The median cost of dialysis was found at 47.5 $; the median cost of hospitalization was found to be 142.6 $. The treatment’s median direct cost was 188.5 $, followed by the overall median cost of 295.6 $. The maximum overall cost of treatment was observed at 603.9 $. It was observed that that maximum LOS was found to be 14 days for patients having BPS between 140 to 159 mmHg and BPD between 110- 119 mmHg, and minimum LOS was found to be 3.5 days. Conclusion: The present study highlighted that diabetes co-existing hypertension poses a high economic burden on patients. This study explored that highly significant result for BPS, BPD, FBS, and HbA1c, whereas the significant results were obtained when RBS is compared with LOS and treatment costs. Our study concluded that mean difference of 9.24 $ in patients having FBS: 261-290 mg/dl and > 290 mg/dL. The LOS increases 6.57 days for patients with BPS between 140-159 mmHg compared to BPS between 180 -above 209 mmHg, which lower treatment costs by -21.31$. Keywords: Diabetes, Hypertension, length of stay, cost of treatment, direct medical cost, indirect medical cost

Peer review status:ACCEPTED

26 Nov 2020Submitted to International Journal of Clinical Practice
26 Nov 2020Submission Checks Completed
26 Nov 2020Assigned to Editor
27 Nov 2020Reviewer(s) Assigned
16 Dec 2020Review(s) Completed, Editorial Evaluation Pending
22 Dec 20201st Revision Received
22 Dec 2020Reviewer(s) Assigned
22 Dec 2020Submission Checks Completed
22 Dec 2020Assigned to Editor
29 Dec 2020Review(s) Completed, Editorial Evaluation Pending
03 Jan 2021Editorial Decision: Accept